Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Transfusion
|
November 8, 2005
Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients
Richard J Benjamin, Jeffrey McCullough, Paul D Mintz, et al.
Transfusion
|
November 29, 2025
Amustaline/glutathione pathogen-reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial
Ian J Welsby, Michael E Sekela, Edward L Snyder, et al.
Transfusion
|
February 2, 2010
An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment
Jean-Pierre Cazenave, Chantal Waller, Daniel Kientz, et al.
Transfusion
|
October 2, 2019
Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days
Laura Infanti, Andreas Holbro, Jakob Passweg, et al.
Transfusion
|
April 19, 2025
A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patients
Richard J Benjamin, John P Pitman, Christopher Karim, et al.
British Journal of Haematology
|
March 23, 2011
A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion
Miguel Lozano, Folke Knutson, René Tardivel, et al.
Transfusion
|
March 5, 2020
Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States
Christina L Dean, Jay W Hooper, John M Dye, et al.
Scientific Reports
|
April 7, 2021
Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarray
Rafael Assis, Aarti Jain, Rie Nakajima, et al.
Transfusion
|
August 5, 2005
Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies
Pedro de Alarcon, Richard Benjamin, Marion Dugdale, et al.
Transfusion
|
March 29, 2019
Transfusion of pathogen-reduced platelet components without leukoreduction
Joycelyn Sim, Wai Chiu Tsoi, Cheuk Kwong Lee, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Transfusion
|
November 8, 2005
Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients
Richard J Benjamin, Jeffrey McCullough, Paul D Mintz, et al.
Transfusion
|
November 29, 2025
Amustaline/glutathione pathogen-reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial
Ian J Welsby, Michael E Sekela, Edward L Snyder, et al.
Transfusion
|
February 2, 2010
An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment
Jean-Pierre Cazenave, Chantal Waller, Daniel Kientz, et al.
Transfusion
|
October 2, 2019
Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days
Laura Infanti, Andreas Holbro, Jakob Passweg, et al.
Transfusion
|
April 19, 2025
A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patients
Richard J Benjamin, John P Pitman, Christopher Karim, et al.
British Journal of Haematology
|
March 23, 2011
A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion
Miguel Lozano, Folke Knutson, René Tardivel, et al.
Transfusion
|
March 5, 2020
Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States
Christina L Dean, Jay W Hooper, John M Dye, et al.
Scientific Reports
|
April 7, 2021
Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarray
Rafael Assis, Aarti Jain, Rie Nakajima, et al.
Transfusion
|
August 5, 2005
Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies
Pedro de Alarcon, Richard Benjamin, Marion Dugdale, et al.
Transfusion
|
March 29, 2019
Transfusion of pathogen-reduced platelet components without leukoreduction
Joycelyn Sim, Wai Chiu Tsoi, Cheuk Kwong Lee, et al.
Page
of 7